180 related articles for article (PubMed ID: 23324827)
1. Genetic and pathologic evolution of early secondary gliosarcoma.
Codispoti KE; Mosier S; Ramsey R; Lin MT; Rodriguez FJ
Brain Tumor Pathol; 2014 Jan; 31(1):40-6. PubMed ID: 23324827
[TBL] [Abstract][Full Text] [Related]
2. Gliosarcoma arising from an oligodendroglioma (oligosarcoma).
Hiniker A; Hagenkord JM; Powers MP; Aghi MK; Prados MD; Perry A
Clin Neuropathol; 2013; 32(3):165-70. PubMed ID: 23254140
[TBL] [Abstract][Full Text] [Related]
3. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
[TBL] [Abstract][Full Text] [Related]
4. An IDH1-mutated primary gliosarcoma: case report.
Hsieh JK; Hong CS; Manjila S; Cohen ML; Lo S; Rogers L; Sloan AE
J Neurosurg; 2017 Feb; 126(2):476-480. PubMed ID: 27153165
[TBL] [Abstract][Full Text] [Related]
5. Gliosarcoma arising from oligodendroglioma (Oligosarcoma): A case report with genetic analyses.
Tanaka S; Hitotsumatsu T; Sugita Y; Ishido K; Ito O; Hatae R; Akagi Y; Yoshimoto K; Iihara K
Pathol Int; 2018 Oct; 68(10):567-573. PubMed ID: 30246385
[TBL] [Abstract][Full Text] [Related]
6. The glial and mesenchymal elements of gliosarcomas share similar genetic alterations.
Boerman RH; Anderl K; Herath J; Borell T; Johnson N; Schaeffer-Klein J; Kirchhof A; Raap AK; Scheithauer BW; Jenkins RB
J Neuropathol Exp Neurol; 1996 Sep; 55(9):973-81. PubMed ID: 8800093
[TBL] [Abstract][Full Text] [Related]
7. Gliosarcoma: distinct molecular pathways and genomic alterations identified by DNA copy number/SNP microarray analysis.
Lowder L; Hauenstein J; Woods A; Chen HR; Rupji M; Kowalski J; Olson JJ; Saxe D; Schniederjan M; Neill S; Weinberg B; Sengupta S
J Neurooncol; 2019 Jul; 143(3):381-392. PubMed ID: 31073965
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.
Actor B; Cobbers JM; Büschges R; Wolter M; Knobbe CB; Lichter P; Reifenberger G; Weber RG
Genes Chromosomes Cancer; 2002 Aug; 34(4):416-27. PubMed ID: 12112531
[TBL] [Abstract][Full Text] [Related]
9. Gliosarcomas with the
Wang L; Sun J; Li Z; Chen L; Fu Y; Zhao L; Liu L; Wei Y; Teng L; Lu D
J Clin Pathol; 2017 Dec; 70(12):1079-1083. PubMed ID: 28775171
[TBL] [Abstract][Full Text] [Related]
10. Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma.
Oh JE; Ohta T; Nonoguchi N; Satomi K; Capper D; Pierscianek D; Sure U; Vital A; Paulus W; Mittelbronn M; Antonelli M; Kleihues P; Giangaspero F; Ohgaki H
Brain Pathol; 2016 Jul; 26(4):517-22. PubMed ID: 26443480
[TBL] [Abstract][Full Text] [Related]
11. Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells.
Biernat W; Aguzzi A; Sure U; Grant JW; Kleihues P; Hegi ME
J Neuropathol Exp Neurol; 1995 Sep; 54(5):651-6. PubMed ID: 7666053
[TBL] [Abstract][Full Text] [Related]
12. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.
Cachia D; Kamiya-Matsuoka C; Mandel JJ; Olar A; Cykowski MD; Armstrong TS; Fuller GN; Gilbert MR; De Groot JF
J Neurooncol; 2015 Nov; 125(2):401-10. PubMed ID: 26354773
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features of primary and postirradiation cerebral gliosarcoma.
Perry JR; Ang LC; Bilbao JM; Muller PJ
Cancer; 1995 Jun; 75(12):2910-8. PubMed ID: 7773942
[TBL] [Abstract][Full Text] [Related]
14. Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma.
Kiang KM; Chan AA; Leung GK
BMC Cancer; 2021 Mar; 21(1):265. PubMed ID: 33706745
[TBL] [Abstract][Full Text] [Related]
15. Gliosarcoma arising from oligodendroglioma, IDH mutant and 1p/19q codeleted.
Yasuda T; Nitta M; Komori T; Kobayashi T; Masui K; Maruyama T; Sawada T; Muragaki Y; Kawamata T
Neuropathology; 2018 Feb; 38(1):41-46. PubMed ID: 28812310
[TBL] [Abstract][Full Text] [Related]
16. Preferential recurrence of a sarcomatous component of a gliosarcoma after boron neutron capture therapy: case report.
Miyatake S; Kuwabara H; Kajimoto Y; Kawabata S; Yokoyama K; Doi A; Tsuji M; Mori H; Ono K; Kuroiwa T
J Neurooncol; 2006 Jan; 76(2):143-7. PubMed ID: 16234987
[TBL] [Abstract][Full Text] [Related]
17. Sarcomatous evolution of oligodendroglioma ("oligosarcoma"): confirmatory report of an uncommon pattern of malignant progression in oligodendroglial tumors.
Vajtai I; Vassella E; Hewer E; Kappeler A; Reinert MM
Pathol Res Pract; 2012 Dec; 208(12):750-5. PubMed ID: 23102810
[TBL] [Abstract][Full Text] [Related]
18. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry.
Sreenan JJ; Prayson RA
Arch Pathol Lab Med; 1997 Feb; 121(2):129-33. PubMed ID: 9126039
[TBL] [Abstract][Full Text] [Related]
19. Transformation of IDH-wildtype glioblastoma to gliosarcoma with features of osteosarcoma.
Sobczyk P; Sobstyl M; Acewicz A; Rosa J; Grabiec M; Grajkowska W
Folia Neuropathol; 2024; 62(1):96-101. PubMed ID: 38741436
[TBL] [Abstract][Full Text] [Related]
20. Gliosarcoma with osteosarcomatous component: A case report and short review illustration.
Chen Y; Zhou S; Zhou X; Dai X; Wang L; Chen P; Zhao S; Shi C; Xiao S; Dong J
Pathol Res Pract; 2022 Apr; 232():153837. PubMed ID: 35278815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]